{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Menatetrenone",
  "nciThesaurus": {
    "casRegistry": "863-61-6",
    "chebiId": "",
    "chemicalFormula": "C31H40O2",
    "definition": "A menaquinone compound and form of vitamin K2 with potential antineoplastic activity. Menatetrenone may act by modulating the signalling of certain tyrosine kinases, thereby affecting several transcription factors including c-myc and c-fos. This agent inhibits tumor cell growth by inducing apoptosis and cell cycle arrest.",
    "fdaUniiCode": "27Y876D139",
    "identifier": "C52194",
    "preferredName": "Menatetrenone",
    "semanticType": "Pharmacologic Substance",
    "subclassOf": [
      "C26017"
    ],
    "synonyms": [
      "2-Methyl-3-trans-tetraprenyl-1,4-naphthoquinone",
      "E0167",
      "MENATETRENONE",
      "Menaquinone K4",
      "Menaquinone-4",
      "Menatetrenone",
      "Vitamin MK 4"
    ]
  }
}